Research SCIENTISTS
How we can help
Researchers benefit from Ximbio’s expertise and experience in sourcing and commercialising their reagents. We help to make your reagents available to scientists worldwide through our networks of commercial partners, suppliers and institutions.
Ximbio is a non-profit dedicated to making life science research reagents widely and easily available to you and other scientists, to accelerate life science research. We do this by maintaining and commercialising a portfolio of reagents worldwide.
Why use Ximbio?
Simplify the commercialisation of your reagents
We identify and commercialise your reagents for you, reducing your administration burden
Generate income for you and your institute
We share any revenue generated from the commercialisation of your reagents with you and your institute
Increase your profile
Ximbio partners with more than 70 institutions worldwide, ensuring the widest possible visibility of your reagents
Save time
Ximbio provides a ‘one stop shop’ for all your reagent needs, from identifying reagents with commercial potential that often go to waste in the back of freezers or are lost when researchers leave, to managing and responding to enquiries about your reagents on your behalf
Be more efficient
We can help you source relevant reagents for your research quickly and simply
Build a network
The Ximbio portfolio allows you to share your reagents with over 200 life science companies worldwide
Support cancer research
Ximbio is a non-profit that is part of the technology transfer licensing team within Cancer Research UK (CRUK). Ximbio’s share of the revenue generated from commercialising reagents is fed directly back to CRUK to continue investment in cancer research
Our experience
More than 7900 researchers from 1900 institutes worldwide, have already connected with Ximbio to source reagents.
Discover 5 reasons why other researchers have chosen to partner with Ximbio
Learn MoreSucces Story - Anne Lykkesfeldt
Former Head of Department, Breast Cancer Research at the Danish Cancer Society
Read Success Story